Unlocking the Potential of C4orf36: A drug Target and Biomarker

Target Name: C4orf36

NCBI ID: G132989

C4orf36

Other Name(s): C4orf36 variant 1 | chromosome 4 open reading frame 36 | Uncharacterized protein C4orf36 | Chromosome 4 open reading frame 36, transcript variant 1 | CD036_HUMAN

Unlocking the Potential of C4orf36: A drug Target and Biomarker

C4orf36, also known as C4orf36 variant 1, is a protein that is expressed in various tissues and cell types in the human body. Its unique structure and expression pattern have piqued the interest of researchers due to its potential involvement in various diseases. This article will explore the potential implications of C4orf36 as a drug target and biomarker.

C4orf36: A protein and its variants

C4orf36 is a member of the BCL-2 (Bcl-2-associated lymphoid gene 2) family, which is known for its role in regulating apoptosis (programmed cell death) and cell survival. The BCL-2 family plays a crucial role in maintaining tissue homeostasis, and dysregulation of BCL-2 has been implicated in various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.

C4orf36 variants

C4orf36 has four known variants, which are named based on their unique expression levels in different tissues. These variants include C4orf36-low, C4orf36-normal, C4orf36-high, and C4orf36-extra. The expression and function of each variant have been studied extensively to determine its potential implications in various diseases.

C4orf36 as a drug target

C4orf36 has been shown to play a critical role in several cellular processes, including cell apoptosis, cell cycle regulation, and tissue homeostasis. Its unique structure and expression pattern make it an attractive target for small molecules. Researchers have identified several potential drug candidates that can interact with C4orf36 and are currently in the process of evaluating their efficacy.

C4orf36 as a biomarker

C4orf36 has also been used as a biomarker for several diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Its expression patterns have been used to diagnose and monitor disease progression in various patient populations. For example, C4orf36-normal has been used as a biomarker for neurodegenerative diseases, and C4orf36-high has been used as a biomarker for cancer.

Conclusion

C4orf36 is a protein that has significant implications in various diseases due to its unique structure and expression pattern. As a drug target, C4orf36 has the potential to treat a variety of conditions, including cancer, neurodegenerative disorders, and autoimmune diseases. As a biomarker, C4orf36 can be used to diagnose and monitor disease progression in various patient populations. Further research is needed to fully understand the potential of C4orf36 as a drug target and biomarker, and to develop safe and effective treatments.

Protein Name: Chromosome 4 Open Reading Frame 36

The "C4orf36 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C4orf36 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets